Carticel (Genzyme Corporation)


Welcome to the PulseAid listing for the Carticel drug offered from Genzyme Corporation. This Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Chondrocytes [Chemical/Ingredient] pharmaceutical is classified as a CELLULAR THERAPY. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same CELLULAR THERAPY drug type category.

LABELER NAME / MANUFACTURER: Genzyme Corporation
NON-PROPRIETARY NAME: autologous cultured chondrocytes
SUBSTANCE NAME: AUTOLOGOUS CULTURED CHONDROCYTES
TYPE: CELLULAR THERAPY
PHARMA CLASS: Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Chondrocytes [Chemical/Ingredient]
ROUTE: INTRA-ARTICULAR
DOSAGE FORM: IMPLANT
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1997-08-22
END MARKETING DATE: 0000-00-00


Carticel CELLULAR THERAPY Details:

Item DescriptionCarticel from Genzyme Corporation
LABELER NAME: Genzyme Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 12000000(1-Jan)
START MARKETING DATE: 1997-08-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 58468-1025_4e992833-70ee-4307-9d51-5a351ed92e9d
PRODUCT NDC: 58468-1025
APPLICATION NUMBER: BLA103661

Other AUTOLOGOUS CULTURED CHONDROCYTES Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Genzyme CorporationCarticel
Vericel CorporationCARTICEL